Open AccessIdentification of a Vulnerable Group for Post-Acute Sequelae of SARS-CoV-2 (PASC): People with Autoimmune Diseases Recover More Slowly from COVID-19
Author(s) -
Nancy A Dreyer,
Natalia PetruskiIvleva,
Lisa Albert,
Damir Mohamed,
Emma Brinkley,
Matthew W. Reynolds,
Stephen Toovey
Publication year - 2021
Publication title -
international journal of general medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.722
H-Index - 36
ISSN - 1178-7074
DOI - 10.2147/ijgm.s313486
Subject(s) - medicine , logistic regression , covid-19 , disease , odds ratio , severity of illness , persistence (discontinuity) , odds , pediatrics , infectious disease (medical specialty) , geotechnical engineering , engineering
Evidence is emerging that a significant percentage of COVID-19 cases experience symptom persistence beyond 30 days and go on to develop post-acute sequelae. Our objective was to compare the risk for COVID-19 symptom persistence by self-reported use of medications for autoimmune disease among participants of an on-line COVID-19 registry.